RW

Ross Weinreb Goldman Sachs Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
RLMD icon
1
Relmada Therapeutics
RLMD
$54.4M
$1.64 $53
3,132%
upside
Buy 24 Mar ‘22
3 years ago